Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    " September 30, 2009":" October 30, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style Community
Conditions: HIV Infection;   HIV Infections
Intervention:
2 Active, not recruiting Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Conditions: Parkinson's Disease;   HIV Infections
Intervention:
3 Completed Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort
Condition: HIV Infections
Intervention:
4 Completed Europe-Africa Research Network for Evaluation of Second-line Therapy
Conditions: Human Immunodeficiency Virus;   HIV
Interventions: Drug: Aluvia + 2NRTIs;   Drug: Aluvia + raltegravir;   Drug: Aluvia monotherapy
5 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
6 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
7 Completed Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Conditions: Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
Intervention: Drug: Pegylated interferon alfa-2a and Ribavirin
8 Terminated
Has Results
Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
9 Completed QoL and Adherence to One-pill Once-a-day HAART
Conditions: HIV Infection;   HIV Infections
Intervention: Other: reduced number of pills
10 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
11 Unknown  Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
12 Unknown  Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
13 No longer available A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Open Label Treatment Access: Maraviroc
14 Active, not recruiting Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Conditions: Fetal Alcohol Syndrome;   HIV;   Nutrition Disorders
Intervention: Behavioral: Philani Intervention Program
15 Completed The Women's HIV SeroIncidence Study (ISIS)
Condition: HIV Infections
Intervention:
16 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Conditions: HIV Infections;   H1N1 Influenza
Intervention: Biological: Arepanrix
17 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
18 Completed Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX-B;   Biological: IL-12 DNA plasmids
19 Completed
Has Results
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
Conditions: HIV Infections;   Heart Disease
Interventions: Drug: Lovaza;   Drug: Placebo
20 Completed TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: TMC278; Omeprazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years